Pro-apoptotic polymers for neutrophil-induced inflammation modulation: from screening to therapeutic potential
Abstract
Human polymorphonuclear neutrophils (PMNs) are pivotal in the initiation and resolution of inflammation, playing an essential role in maintaining tissue homeostasis and facilitating repair. This study investigates how polymers influence PMNs apoptosis, a favourable step for the resolution of inflammation, identifying poly(arginine) containing 30 arginine subunits (PAR30) as a potent pro-apoptotic agent. Further mechanistic analysis suggests that PAR30 induces apoptosis predominantly through mitochondrial ROS production, which in turn activates caspases 3 and 7 through the intrinsic apoptotic pathway. Remarkably, PMNs treated with PAR30 exhibit enhanced recognition and phagocytosis by macrophages, suggesting an overall more efficient clearance of apoptotic cells. These findings underscore PAR30 potential as a therapeutic agent for modulating inflammatory processes by promoting PMNs apoptosis and improving macrophage-mediated efferocytosis. Moreover, preliminary exploration of PAR30 chemical modifications in order to enhance its intracellular penetration, suggests that the pro-apoptotic effect could be enhanced, as displayed by increased annexin-V staining mediated by thiolated-PAR30. PAR30-based compounds appear as novel anti-inflammatory agents, capable of promoting neutrophil apoptosis and enhancing macrophage-mediated clearance, paving the way for therapeutic applications in difficult-to-treat inflammatory diseases.
Related
- Renoprotective Effects of Vortioxetine in Experimental Renal Ischemia–Reperfusion Injury: An Investigation of Oxidative Stress, Inflammation, and Apoptotic Signaling
- In vitro effects of benzydamine on metabolic viability, clonogenic capacity, apoptotic profile, cell-cycle distribution, and inflammation-related gene expression in SH-SY5Y neuroblastoma cells
- Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting
- The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
- Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities
BibTeX
@article{frisch2026proapoptotic,
title = {{Pro-apoptotic polymers for neutrophil-induced inflammation modulation: from screening to therapeutic potential}},
author = {Emilie Frisch and Candice Dussouillez and Philippe Lavalle and Antoine Kichler and Benoît Frisch and Viola Mazzoleni and Béatrice Heurtault},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-70767-0},
url = {https://hal.science/hal-05768483v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Pro-apoptotic polymers for neutrophil-induced inflammation modulation: from screening to therapeutic potential
AU - Emilie Frisch
AU - Candice Dussouillez
AU - Philippe Lavalle
AU - Antoine Kichler
AU - Benoît Frisch
AU - Viola Mazzoleni
AU - Béatrice Heurtault
PY - 2026
DA - 2026/09/25
JO - Scientific Reports
DO - 10.1038/s41598-026-70767-0
UR - https://hal.science/hal-05768483v1
AB - Human polymorphonuclear neutrophils (PMNs) are pivotal in the initiation and resolution of inflammation, playing an essential role in maintaining tissue homeostasis and facilitating repair. This study investigates how polymers influence PMNs apoptosis, a favourable step for the resolution of inflammation, identifying poly(arginine) containing 30 arginine subunits (PAR30) as a potent pro-apoptotic agent. Further mechanistic analysis suggests that PAR30 induces apoptosis predominantly through mitochondrial ROS production, which in turn activates caspases 3 and 7 through the intrinsic apoptotic pathway. Remarkably, PMNs treated with PAR30 exhibit enhanced recognition and phagocytosis by macrophages, suggesting an overall more efficient clearance of apoptotic cells. These findings underscore PAR30 potential as a therapeutic agent for modulating inflammatory processes by promoting PMNs apoptosis and improving macrophage-mediated efferocytosis. Moreover, preliminary exploration of PAR30 chemical modifications in order to enhance its intracellular penetration, suggests that the pro-apoptotic effect could be enhanced, as displayed by increased annexin-V staining mediated by thiolated-PAR30. PAR30-based compounds appear as novel anti-inflammatory agents, capable of promoting neutrophil apoptosis and enhancing macrophage-mediated clearance, paving the way for therapeutic applications in difficult-to-treat inflammatory diseases.
SN - 2045-2322
ER -